COCH (Envoy Medical) Float Percentage Of Total Shares Outstanding: 59.61% (As of Jul. 09, 2026)


COCH Envoy Medical Inc COCH
24 GF Score
Price $0.73
GF Value $1.13
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Envoy Medical Float Percentage Of Total Shares Outstanding?

Envoy Medical COCH -7.58% 24 Float Percentage Of Total Shares Outstanding is 59.61% as of Jul. 09, 2026. GuruFocus rates COCH with a GF Score™ of 24/100 and a GF Value™ of $1.13 (Possible Value Trap). The stock has 6 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Envoy Medical's float shares is 45.91 Mil. Envoy Medical's total shares outstanding is 77.02 Mil. Envoy Medical's float percentage of total shares outstanding is 59.61%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Envoy Medical's Insider Ownership is 31.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Envoy Medical's Institutional Ownership is 23.04%.

COCH
24GF Score
Envoy Medical Inc COCH
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Envoy Medical Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Envoy Medical's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=45.91/77.02
=59.61%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 59.61% mean?
Envoy Medical (COCH) has a Float Percentage Of Total Shares Outstanding of 59.61% as of Jul. 09, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Envoy Medical and its competitors.
Is Envoy Medical's Float Percentage Of Total Shares Outstanding too high?
Envoy Medical's current Float Percentage Of Total Shares Outstanding is 59.61%. Overall, Envoy Medical has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Envoy Medical's Float Percentage Of Total Shares Outstanding compare to SRTS and QTI?
Envoy Medical's Float Percentage Of Total Shares Outstanding of 59.61% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Envoy Medical and its competitors. Envoy Medical's current Float Percentage Of Total Shares Outstanding is 59.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envoy Medical stock overvalued right now?
Based on GuruFocus' analysis, Envoy Medical (COCH) is currently considered Possible Value Trap. The stock's GF Value™ is $1.13, compared to a current price of $0.73 — trading 35.8% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 59.61%. Envoy Medical's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Envoy Medical (COCH), the current Float Percentage Of Total Shares Outstanding is 59.61% as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Envoy Medical (COCH) Overvalued in 2026?

Based on GuruFocus' analysis, Envoy Medical stock appears to be undervalued. The current stock price of $0.73 is trading 35.8% below its estimated GF Value™ of $1.13. GuruFocus considers Envoy Medical to be Possible Value Trap.

Key valuation signals for COCH:

  • Float Percentage Of Total Shares Outstanding: 59.61%
  • GF Value™: $1.13 vs. price of $0.73 (35.8% below fair value)
  • GF Score™: 24/100 with 6 warning signs

No single metric tells the full story. See the COCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Envoy Medical Business Description

Address 4875 White Bear Parkway, White Bear Lake, MN, USA, 55110
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
24GF Score

Get the complete analysis for COCH

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.73
Price
$1.13
GF Value